New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
08:55 EDTNVS, NVS, NVS, PG, PG, PGFDA to hold a public hearing
The FDA holds a public hearing on the Over-the-Counter Drug Monograph System at FDA Silver Spring, Maryland offices on March 25-26 at 9 am. Webcast Link
News For NVS;PG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 13, 2014
13:26 EDTNVSLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including Leukemia/MDS on an Analyst/Industry conference call to be held on November 20 at 10 am.
12:44 EDTPGOn The Fly: Midday Wrap
Subscribe for More Information
08:40 EDTPGProcter & Gamble says top line comps are more difficult in Q2 vs 2H15
Subscribe for More Information
07:44 EDTPGProcter & Gamble to restate Batteries results to discontinued operations
Subscribe for More Information
07:44 EDTPGP&G to incur non-cash charge of approx. 28c per share in current quarter
07:42 EDTPGProcter & Gamble sees FY15 core EPS growth mid-single digits
Subscribe for More Information
07:41 EDTPGProcter and Gamble volatility flat into Berkshire Hathaway acquiring Duracell
Procter and Gamble (PG) overall option implied volatility of 13 is near its 26-week average of 14 according to Track Data, suggesting non-directional price movement into Berkshire Hathaway Inc. (BRK.B) acquiring the Duracell battery business from Procter & Gamble in deal valued at approximately $6.4B.
07:40 EDTPGProcter & Gamble reiterates FY15 organic sales, core EPS growth guidance
Subscribe for More Information
07:40 EDTPGProcter & Gamble sees clsoing Duracell transaction in 2H15
Following its prior announcement of plans to exit the Duracell business, P&G (PG) said it now plans to execute a split transaction, in which it will exchange a recapitalized Duracell Company for Berkshire Hathaway’s (BRK.A) shares of P&G stock. Berkshire’s stock ownership is currently valued at approximately $4.7 billion. P&G said it expects to contribute approximately $1.8 billion in cash to the Duracell Company in the pre-transaction recapitalization. P&G said the transaction maximizes the after-tax value of the Duracell business and is tax efficient for P&G. The value received for Duracell in the exchange is approximately 7-times fiscal year 2014 adjusted EBITDA. This equates to a cash sale valued at approximately 9-times adjusted EBITDA. As part of the exit of the battery business, P&G announced that it closed the sale of its interest in a China-based battery joint venture earlier in the week. Based on the signing of the contract to exit the Duracell business, P&G will restate Batteries results to discontinued operations effective with the reporting of October-December 2014 quarterly results. The Company expects to restate earnings per share of approximately 12c-14c to discontinued operations for fiscal year 2014. All-in GAAP earnings per share are not affected by the restatements. P&G said it will incur a non-core, non-cash charge of approximately 28c per share in current quarter results to adjust Duracell goodwill and intangible assets to the expected after-tax transaction value. P&G expects to finalize the restatement and one-time charge amounts in the next few weeks, and will update shareholders when final amounts are available. P&G said it expects to close the Duracell transaction in the second half of calendar year 2015 pending necessary regulatory approvals.
07:31 EDTPGBerkshire Hathaway to acquire Procter & Gamble's Duracell battery business
Subscribe for More Information
07:30 EDTPGBerkshire Hathaway to acquire Procter & Gamble's Duracell battery business
Subscribe for More Information
November 12, 2014
11:17 EDTNVSLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
08:18 EDTNVSUBS to hold a conference
Subscribe for More Information
07:58 EDTNVSGenVec expects 2014 cash burn between $6M-$7M from Novartis collaboration
Subscribe for More Information
November 11, 2014
16:14 EDTNVSLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including JAK inhibitors, novel Jakafi combinations for Myelofibrosis and developing compounds on an Analyst/Industry conference call to be held on November 17 at 10 am.
16:01 EDTNVSQIAGEN enters master collaboration agreement with Novartis
Subscribe for More Information
15:43 EDTNVSLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
November 10, 2014
16:07 EDTNVSUBS to hold a conference
UBS European Conference is being held in London, England on November 11-12.
15:57 EDTNVSWorldwide Business Research to hold a conference
ProcureCon for Digital & Marketing Services 2014 is being held in San Antonio on November 11-13.
13:56 EDTPGProcter & Gamble to host analyst meeting
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use